Updated MUR medicines for national target group
From 1 April 2020 to 31 March 2021, at least 70% of MUR service consultations should be done with patients in at least one of the 2 national target groups:
- patients taking a high-risk medicine
- patients who’ve been discharged from hospital in the last 8 weeks and had changes made to the drugs they're taking while in hospital
MUR drug list
These products are classified as MUR medicines for patients taking high-risk medicines, as outlined in Part VIC of the drug tariff.
You can view the high-risk medicines, last updated February 2021:
As outlined in Part VIC of the drug tariff, you should only do NMS with patients who’ve, for the first time, been prescribed a particular NMS medicine for the following conditions.
You can view each condition and its drug list, last updated February 2021:
Asthma and Chronic Obstructive Pulmonary Disease drug list (Excel: 12KB)Type 2 diabetes drug list (Excel: 9KB)Antiplatelet/Anticoagulant Therapy drug list (Excel: 9KB)Hypertension drug list (Excel: 11KB)